74896-30-3

Basic information

• Product Name: N-(5-acetyl-2-hydroxyphenyl)acetamide
• CAS NO: 74896-30-3
• Molecular Formula: C₁₀H₁₁NO₃
• Molecular Weight: 193.1992
• Mol File: 74896-30-3.mol
• Article Data: 8

Chemical Properties

• Boiling Point: 446°C at 760 mmHg
• Flash Point: 223.5°C
• Density: 1.267g/cm³
• Vapor Pressure: 1.44E-08mmHg at 25°C
• Refractive Index: 1.603
• CAS DataBase Reference: N-(5-acetyl-2-hydroxyphenyl)acetamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-(5-acetyl-2-hydroxyphenyl)acetamide(74896-30-3)
• EPA Substance Registry System: N-(5-acetyl-2-hydroxyphenyl)acetamide(74896-30-3)

Safety Data

• Hazardous Substances Data: 74896-30-3(Hazardous Substances Data)

Upstream product

• 54255-50-4 3-amino-4-hydroxyacetophenone 
• 108-24-7 acetic anhydride 
• 6322-56-1 4'-hydroxy-3'-nitroacetophenone 
• 75-36-5 acetyl chloride 
• 614-80-2 2-(acetylamino)phenol 
• 5467-64-1 2-acetamidophenyl acetate 

Downstream Products

• 54255-50-4 3-amino-4-hydroxyacetophenone 
• 151719-72-1 1-<3-(acetylamino)-4-(3-chloropropoxy)phenyl>ethanone 
• 1201079-07-3 1-(3-acetamido-4-ethoxyphenyl)ethanone 
• 1201079-10-8 1-(5-acetamido-4-ethoxy-2-nitrophenyl)ethanone 
• 1201080-09-2 N-(3-cyano-7-ethoxy-4-oxo-1,4-dihydroquinolin-6-yl)acetamide 
• 848133-76-6 7-ethoxy-6-acetylamino-4-chloro-quinoline-3-carbonitrile 

Relevant articles and documents

New synthesis of N -(4-chloro-3-cyano-7-ethoxyquinolin-6-yl)acetamide

-

Fibrinogen receptor antagonists and their use

This invention relates to novel fused bicyclic compounds of the general formula (I): wherein the symbols are defined herein, to pharmaceutical compositions containing the compounds, processes for preparing the compounds, and to methods of using the compounds, alone or in combination with other therapeutic agents. The compounds are antagonists of the platelet glycoprotein IIb/IIIa fibrinogen receptor complex, and are therefore useful for the inhibition of platelet aggregation, and for the treatment of thrombotic diseases and other diseases.

FIBRINOGEN RECEPTOR ANTAGONISTS AND THEIR USE

This invention relates to novel fused bicyclic compounds of the general formula (I): wherein the symbols are defined herein, to pharmaceutical compositions containing the compounds, processes for preparing the compounds, and to methods of using the compounds, alone or in combination with other therapeutic agents. The compounds are antagonists of the platelet glycoprotein IIb/IIIa fibrinogen receptor complex, and are therefore useful for the inhibition of platelet aggregation, and for the treatment of thrombotic diseases and other diseases.